Climara and Actonel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Climara (estradiol) and Actonel (risedronate sodium). Common drug interactions include postoperative renal failure among females and bone density decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Climara and Actonel. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Climara?

Climara has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 6,706 Climara users. Check the latest studies of Climara.

What is Actonel?

Actonel has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 29,369 Actonel users. Check the latest studies of Actonel.



On Jul, 13, 2026

35 people who take Climara and Actonel together, and have interactions are studied.

Climara and Actonel drug interactions.

What are the common drug interactions of Climara and Actonel, by gender? *:

female:

  1. Postoperative renal failure
  2. Psoriasis (immune-mediated disease that affects the skin)
  3. Restless legs syndrome (a powerful urge to move your legs)
  4. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  5. Surgery
  6. Urinary tract infection
  7. Vertigo
  8. Agitation (state of anxiety or nervous excitement)
  9. Alanine aminotransferase increased
  10. Arthropathy

male:

  1. Bone density decreased
  2. Calcium deficiency (lack of calcium)
  3. Injection site swelling
  4. Ligament sprain (ligament stretched)
  5. Osteoporotic fracture (fracture due to weak bone)
  6. Spinal compression fracture (fracture due to spinal compression on bone)
  7. Spinal fracture (fracture in one of vertebrae)
  8. Vitamin d deficiency
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Cubital tunnel syndrome (a condition brought on by increased pressure on the ulnar nerve at the elbow)

What are the common drug interactions of Climara and Actonel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hyperthermia (body temperature greatly above normal)
  2. Hypotension (abnormally low blood pressure)
  3. Leukopenia (less number of white blood cells in blood)
  4. Petechiae (a small red or purple spot caused by bleeding into the skin)
  5. Serositis (inflammation of the serous tissues of the body)
  6. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Agitation (state of anxiety or nervous excitement)
  9. Cardiac disorder
  10. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

50-59:

  1. Osteonecrosis (death of bone)
  2. Respiratory disorder (respiratory disease)
  3. Small intestinal haemorrhage (bleeding from small intestine)
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Tooth disorder (tooth disease)
  6. Toothache (tooth pain)
  7. Vomiting
  8. Anxiety
  9. Electrocardiogram qt prolonged
  10. Pruritus (severe itching of the skin)

60+:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Bone disorder
  3. Cubital tunnel syndrome (a condition brought on by increased pressure on the ulnar nerve at the elbow)
  4. Epicondylitis (tennis elbow)
  5. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  6. Injection site erythema (redness at injection site)
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site rash
  9. Injection site reaction
  10. Injection site swelling

What are the existing conditions these people have? *

  1. Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 22.86%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 20.00%
  3. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 5 people, 14.29%
  4. Thyroid Diseases: 2 people, 5.71%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.71%
  6. Pituitary Tumor Benign: 2 people, 5.71%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.71%
  8. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 5.71%
  9. Constipation: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Climara and Actonel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Climara and Actonel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Climara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actonel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Climara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actonel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on estradiol and risedronate sodium (the active ingredients of Climara and Actonel, respectively), and Climara and Actonel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: